Albert Cha - Net Worth and Insider Trading
Albert Cha Net Worth
The estimated net worth of Albert Cha is at least $60 Million dollars as of 2024-11-10. Albert Cha is the Director of Biohaven Pharmaceutical Holding Co Ltd and owns about 3,483,636 shares of Biohaven Pharmaceutical Holding Co Ltd (BHVN) stock worth over $49 Million. Albert Cha is the Director of Aclaris Therapeutics Inc and owns about 4,191,397 shares of Aclaris Therapeutics Inc (ACRS) stock worth over $11 Million. Albert Cha is also the Director of VYNE Therapeutics Inc and owns about 55,712 shares of VYNE Therapeutics Inc (VYNE) stock worth over $176,050. Besides these, Albert Cha also holds KalVista Pharmaceuticals Inc (KALV) . Details can be seen in Albert Cha's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Albert Cha has not made any transactions after 2023-09-11 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Albert Cha
Albert Cha Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Albert Cha owns 7 companies in total, including KalVista Pharmaceuticals Inc (KALV) , Biohaven Pharmaceutical Holding Co Ltd (BHVN) , and VYNE Therapeutics Inc (VYNE) among others .
Click here to see the complete history of Albert Cha’s form 4 insider trades.
Insider Ownership Summary of Albert Cha
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| KALV | KalVista Pharmaceuticals Inc | 2023-09-11 | director |
| BHVN | Biohaven Pharmaceutical Holding Co Ltd | 2017-05-09 | director |
| VYNE | VYNE Therapeutics Inc | 2018-01-25 | director |
 | | 2015-10-13 | director |
| | 2015-07-15 | director & 10 percent owner |
| | 2014-11-12 | 10 percent owner |
| | 2007-05-10 | director |
Albert Cha Latest Holdings Summary
Albert Cha currently owns a total of 4 stocks. Among these stocks, Albert Cha owns 3,483,636 shares of Biohaven Pharmaceutical Holding Co Ltd (BHVN) as of May 9, 2017, with a value of $49 Million and a weighting of 81.41%. Albert Cha owns 4,191,397 shares of Aclaris Therapeutics Inc (ACRS) as of October 13, 2015, with a value of $11 Million and a weighting of 18.3%. Albert Cha also owns 55,712 shares of VYNE Therapeutics Inc (VYNE) as of January 25, 2018, with a value of $176,050 and a weighting of 0.29%. The other 1 stocks KalVista Pharmaceuticals Inc (KALV) have a combined weighting of 0% among all his current holdings.
Latest Holdings of Albert Cha
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BHVN | Biohaven Pharmaceutical Holding Co Ltd | 2017-05-09 | 3,483,636 | 14.08 | 49,049,595 |
| ACRS | Aclaris Therapeutics Inc | 2015-10-13 | 4,191,397 | 2.63 | 11,023,374 |
| VYNE | VYNE Therapeutics Inc | 2018-01-25 | 55,712 | 3.16 | 176,050 |
| KALV | KalVista Pharmaceuticals Inc | 2023-09-11 | 0 | 11.41 | 0 |
Holding Weightings of Albert Cha
Albert Cha Form 4 Trading Tracker
According to the SEC Form 4 filings, Albert Cha has made a total of 0 transactions in Biohaven Pharmaceutical Holding Co Ltd (BHVN) over the past 5 years. The most-recent trade in Biohaven Pharmaceutical Holding Co Ltd is the acquisition of 470,000 shares on May 9, 2017, which cost Albert Cha around $8 Million.
According to the SEC Form 4 filings, Albert Cha has made a total of 0 transactions in Aclaris Therapeutics Inc (ACRS) over the past 5 years. The most-recent trade in Aclaris Therapeutics Inc is the acquisition of 454,545 shares on October 13, 2015, which cost Albert Cha around $5 Million.
According to the SEC Form 4 filings, Albert Cha has made a total of 0 transactions in VYNE Therapeutics Inc (VYNE) over the past 5 years. The most-recent trade in VYNE Therapeutics Inc is the acquisition of 4,085 shares on January 25, 2018, which cost Albert Cha around $5 Million.
More details on Albert Cha's insider transactions can be found in the Insider Trading History of Albert Cha table.Insider Trading History of Albert Cha
- 1
Albert Cha Trading Performance
GuruFocus tracks the stock performance after each of Albert Cha's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Albert Cha is 11.64%. GuruFocus also compares Albert Cha's trading performance to market benchmark return within the same time period. The performance of stocks bought by Albert Cha within 3 months outperforms 4 times out of 8 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Albert Cha's insider trading performs compared to the benchmark.
Performance of Albert Cha
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 12.28 | | | | | |
| Relative Return to S&P 500(%) | 11.41 | | | | | |
Albert Cha Ownership Network
Ownership Network List of Albert Cha
Ownership Network Relation of Albert Cha
Albert Cha Owned Company Details
What does KalVista Pharmaceuticals Inc do?
Who are the key executives at KalVista Pharmaceuticals Inc?
Albert Cha is the director of KalVista Pharmaceuticals Inc. Other key executives at KalVista Pharmaceuticals Inc include CFO and Secretary Benjamin L Palleiko , Chief Medical Officer Paul K. Audhya , and Chief Development Officer Christopher Yea .
KalVista Pharmaceuticals Inc (KALV) Insider Trades Summary
Over the past 18 months, Albert Cha made 1 insider transaction in KalVista Pharmaceuticals Inc (KALV) with a net sale of 18,000. Other recent insider transactions involving KalVista Pharmaceuticals Inc (KALV) include a net purchase of 1,251,017 shares made by Venrock Healthcare Capital Partners Iii, L.p. , a net sale of 144,760 shares made by Benjamin L Palleiko , and a net sale of 116,267 shares made by Edward P. Feener .
In summary, during the past 3 months, insiders sold 40,693 shares of KalVista Pharmaceuticals Inc (KALV) in total and bought 0 shares, with a net sale of 40,693 shares. During the past 18 months, 583,370 shares of KalVista Pharmaceuticals Inc (KALV) were sold and 1,251,017 shares were bought by its insiders, resulting in a net purchase of 667,647 shares.
KalVista Pharmaceuticals Inc (KALV)'s detailed insider trading history can be found in Insider Trading Tracker table.
KalVista Pharmaceuticals Inc Insider Transactions
Albert Cha Mailing Address
Above is the net worth, insider trading, and ownership report for Albert Cha. You might contact Albert Cha via mailing address: 505 Hamilton Avenue, Suite 200, Palo Alto Ca 94301.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
